Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003472
Status:
TERMINATED
Last Update Posted:
2018-03-21
First Post:
1999-11-01
Brief Title:
Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma
Sponsor:
Burzynski Research Institute
Organization:
Burzynski Research Institute
Organization Data
Organization:
Burzynski Research Institute
Class:
OTHER
Study ID:
CDR0000066509
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Burzynski Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None